Charles L. Larson
FDA investigator
Appears on 2 documents from 2017 to 2022, mostly at sites in Arizona. Most often cites corrective and preventive action (21 CFR 820.100(b)).
- 2
- Documents on file
- 3.5
- Observations per 483
- 2017
- First seen
- 2022
- Most recent
What they cite most
From 7 observations- 21 CFR 820.100(b)Corrective and preventive action1
- 21 CFR 820.198(e)Complaint files1
- 21 CFR 820.250(b)Statistical techniques1
- 21 CFR 820.50(a)(1)Purchasing controls1
- 21 CFR 820.75(a)Process validation1
- 21 CFR 820.90(a)Nonconforming product1
Activity by year
2017: 1, 2022: 1
Where
Arizona 1 · California 1
Often inspects with
Is Charles L. Larson coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-02-22 | 483 PARAFFIN USA LLCFeb 22, 2022 · Phoenix, Arizona | Phoenix, Arizona | 3 | |
| 2017-03-03 | 483 Baxter Healthcare CorporationMar 3, 2017 · Irvine, California | Irvine, California | 4 |
About this profile
What does Charles L. Larson inspect?
Charles L. Larson appears on 2 documents on file covering 2 sites, mostly in Arizona.
What do they cite most often?
21 CFR 820.100(b) (corrective and preventive action), followed by 21 CFR 820.198(e) and 21 CFR 820.250(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Charles L. Larson is dated Feb 22, 2022.